LAZZARIN, AMEDEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.179
NA - Nord America 1.145
EU - Europa 459
AF - Africa 196
SA - Sud America 157
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 15
Totale 3.179
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.009
VN - Vietnam 397
SG - Singapore 300
CN - Cina 154
IT - Italia 130
HK - Hong Kong 97
BR - Brasile 84
DE - Germania 40
BD - Bangladesh 38
GB - Regno Unito 35
FR - Francia 34
BJ - Benin 31
NL - Olanda 21
CA - Canada 20
IN - India 18
PL - Polonia 17
MX - Messico 15
CI - Costa d'Avorio 14
IQ - Iraq 14
JP - Giappone 14
FI - Finlandia 13
TR - Turchia 13
EC - Ecuador 12
ES - Italia 12
JM - Giamaica 12
RU - Federazione Russa 11
AR - Argentina 10
PK - Pakistan 10
CW - ???statistics.table.value.countryCode.CW??? 9
LA - Repubblica Popolare Democratica del Laos 9
PA - Panama 9
SI - Slovenia 9
BB - Barbados 8
BO - Bolivia 8
EG - Egitto 8
GM - Gambi 8
MD - Moldavia 8
PY - Paraguay 8
AO - Angola 7
BS - Bahamas 7
CR - Costa Rica 7
DZ - Algeria 7
EE - Estonia 7
GR - Grecia 7
HN - Honduras 7
IL - Israele 7
MA - Marocco 7
PH - Filippine 7
RS - Serbia 7
TH - Thailandia 7
TW - Taiwan 7
ZA - Sudafrica 7
AD - Andorra 6
AE - Emirati Arabi Uniti 6
AL - Albania 6
CL - Cile 6
CM - Camerun 6
CV - Capo Verde 6
CZ - Repubblica Ceca 6
GT - Guatemala 6
LB - Libano 6
LV - Lettonia 6
LY - Libia 6
NC - Nuova Caledonia 6
NP - Nepal 6
PE - Perù 6
TT - Trinidad e Tobago 6
UA - Ucraina 6
UY - Uruguay 6
VE - Venezuela 6
YE - Yemen 6
AT - Austria 5
BZ - Belize 5
CO - Colombia 5
CU - Cuba 5
DK - Danimarca 5
GF - Guiana Francese 5
GH - Ghana 5
IE - Irlanda 5
JO - Giordania 5
KE - Kenya 5
KG - Kirghizistan 5
KR - Corea 5
LT - Lituania 5
ME - Montenegro 5
NE - Niger 5
NG - Nigeria 5
NI - Nicaragua 5
NO - Norvegia 5
RO - Romania 5
RW - Ruanda 5
SE - Svezia 5
SN - Senegal 5
UZ - Uzbekistan 5
VC - Saint Vincent e Grenadine 5
ZW - Zimbabwe 5
AZ - Azerbaigian 4
BE - Belgio 4
BF - Burkina Faso 4
BG - Bulgaria 4
Totale 3.012
Salva come PNG Salva come JPEG
Città #
Ashburn 234
San Jose 229
Singapore 176
Ho Chi Minh City 127
Hanoi 97
Hong Kong 92
Santa Clara 69
Beijing 38
Council Bluffs 38
Los Angeles 38
Cotonou 31
Da Nang 30
Munich 24
Chicago 18
Boardman 16
New York 15
Padova 15
Rome 15
Abidjan 14
Lauterbourg 14
Buffalo 12
Orem 12
Phoenix 12
Baghdad 11
Dallas 10
Haiphong 10
Brooklyn 9
Montreal 9
Tokyo 9
Warsaw 9
Banjul 8
Biên Hòa 8
Hefei 8
Naples 8
Panama City 8
Phủ Lý 8
São Paulo 8
Vientiane 8
Bến Tre 7
Denver 7
London 7
Milan 7
Nassau 7
Andorra la Vella 6
Bridgetown 6
Can Tho 6
Chisinau 6
Helsinki 6
Hải Dương 6
Kingston 6
Luanda 6
Montevideo 6
Noumea 6
Riga 6
Salt Lake City 6
San José 6
Turku 6
Willemstad 6
Atlanta 5
Bangkok 5
Bishkek 5
Bytom 5
Bắc Ninh 5
Dakar 5
Durham 5
Harare 5
Havana 5
Kigali 5
Kingstown 5
La Paz 5
Lahore 5
Ljubljana 5
Nha Trang 5
Nuremberg 5
Podgorica 5
Portomaggiore 5
Redondo Beach 5
San Francisco 5
Terrassa Padovana 5
Thái Bình 5
Venice 5
Ấp Tháp Mười 5
Amman 4
Baku 4
Belgrade 4
Cairo 4
Dubai 4
Frankfurt am Main 4
Hounslow 4
Houston 4
Istanbul 4
Karachi 4
Managua 4
Mexico City 4
Nairobi 4
Niamey 4
Nouakchott 4
Oslo 4
Poplar 4
Port of Spain 4
Totale 1.814
Salva come PNG Salva come JPEG
Nome #
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 326
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 276
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 274
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 258
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 217
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 215
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 213
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 206
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 203
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 194
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 172
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: A longitudinal study 168
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 151
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 149
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 141
Mechano-metabolic feedback connects tissue fluidity to mitochondrial DNA–dependent immunity in breast cancer 16
Totale 3.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.464
article - articoli 9.464
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.928
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024148 0 49 9 13 9 14 20 3 11 5 5 10
2024/2025474 1 65 19 14 44 11 31 52 36 23 81 97
2025/20262.276 130 93 348 299 190 99 525 128 228 121 54 61
2026/2027281 36 98 93 54 0 0 0 0 0 0 0 0
Totale 3.179